Skip to content

Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty

Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03617107
Acronym
rTSA
Enrollment
150
Registered
2018-08-06
Start date
2017-12-15
Completion date
2020-12-31
Last updated
2019-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteo Arthritis Shoulders, Proximal Humeral Fracture, Rotator Cuff Tear, Rotator Cuff Tear Arthropathy

Brief summary

The purpose of this study is to evaluate reverse total shoulder arthroplasty patients preoperative objective measurements and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.

Interventions

OTHERreverse total shoulder arthroplasty

reverse total shoulder arthroplasty

Sponsors

The Orthopaedic Research & Innovation Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. English speaking 2. \>18 years of age 3. Reverse TSA performed by principal investigator

Exclusion criteria

1. Non-English speaking 2. \<18 years of age

Design outcomes

Primary

MeasureTime frameDescription
total operative timepreoperative to up to 8 years postoperativeminutes
amount of blood losspreoperative to up to 8 years postoperativemls

Secondary

MeasureTime frameDescription
Patient Outcomespreoperative to up to 8 years postoperativeAmerican Shoulder and Elbow Surgeon score to measure shoulder function and pain. Scale of 0-100, 100 being the best possible score

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026